#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Cold type haemolytic anaemia Hypoxic-ischaemic encephalopathy Brain stem glioma Scedosporium infection Malignant oligodendroglioma Familial amyotrophic lateral sclerosis Retinopathy of prematurity Pelizaeus-Merzbacher disease Neovascular age-related macular degeneration Li-Fraumeni syndrome Squamous cell carcinoma of the hypopharynx Acute graft versus host disease in skin Hydrocephalus Rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Life with Disease Skin angiosarcoma – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Mantle cell lymphoma – Basic Information Osteosarcoma – Treatment Marginal zone lymphoma refractory – Trials in Disease Antithrombin III deficiency – Diagnostics SAPHO syndrome – Life with Disease Propionic acidaemia – Diagnostics Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vonicog Alfa Sparsentan Allo-501A Giroctocogene Fitelparvovec Ribitol HUMAN COAGULATION FACTOR XIII Rezafungin Acetate Art0380 Mesilate Colchicine Tulmimetostat Prednisone Cloxacillin Degarelix ULIXERTINIB Avutometinib Evencaleucel Vixarelimab Alrefimotide Forimtamig L-SERINE More therapies…

    Learn about Your Condition

    Choreoathetosis Viral infection Breast cancer Knee arthroplasty Dyspepsia Tubulointerstitial nephritis Arrhythmia Still's disease CADASIL Haemoptysis Neurofibromatosis Streptococcal infection Senile dementia Brain stem glioma Meningioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Treating Neovascular Age-Related Macular Degeneration with Aflibercept, Ranibizumab, and Brolucizumab for Patients with Active Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • BROLUCIZUMAB
    • Ranibizumab
    • Aflibercept
    Austria

  • Study on Fibrin Matrix and Autologous Growth Factor Eye Drops for Pterygium Surgery Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pterygium
    Spain

  • Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    3 1
    Investigated Diseases:
    • Age-related macular degeneration
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Austria France Germany Hungary Italy Poland +1

  • Study of Roginolisib for Patients with Advanced Uveal Melanoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Roginolisib
    • Relatlimab
    • Dacarbazine Citrate
    Italy Spain

  • Study on the Effects of Prednisolone Acetate and Placebo Eye Drops for Patients with Chronic Central Serous Chorioretinopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Central serous chorioretinopathy
    Investigated Drugs:
    • Dextran 70
    • Hypromellose
    • Prednisolone Acetate
    The Netherlands

  • Study of atropine eye drops (0.

    Recruiting

    3 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate Monohydrate
    Italy Poland Spain
Previous Page
1 … 4 5 6 7 8 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!